Status:

UNKNOWN

Validation of a Standardized Tool for Evaluation Function of Patients With TMD

Lead Sponsor:

University Hospital, Montpellier

Conditions:

Temporomandibular Joint Disorders

Eligibility:

All Genders

18-75 years

Brief Summary

Temporo-Mandibular Disorders (TMD) are the reason for consultation on more common in maxillofacial. However, there is no consensus on their care. For a long time, Rehabilitative management of the TMD ...

Detailed Description

Temporo-Mandibular Disorders (TMD) are the reason for consultation on more common in maxillofacial. However, there is no consensus on their care. For a long time, Rehabilitative management of the TMD ...

Eligibility Criteria

Inclusion

  • Specific Inclusion criteria :
  • Patients consulting for DTM at the CHU of Montpellier within the CMF service
  • Results obtained with the Helkimo score: moderate to severe
  • Age range: between 18 and 75 years old included
  • Non-specific inclusion criteria:
  • Collection of informed written consent of the patient
  • Affiliation or beneficiary of a social security scheme
  • Non-specific exclusion criteria:
  • Patient under tutorship or curatorship
  • Patient under the protection of justice
  • Specific exclusion criteria:
  • Not included for assessment difficulty:
  • Associated disease or disability that can skew assessments
  • Diseases causing neurological (facial paralysis) or rheumatic (Spondyloarthritis) ankylosing, rheumatoid arthritis) with consequence on TMJ temporomandibular disturbances appeared following a trauma
  • Failure to understand questions or instructions
  • No inclusion for no indication of rehabilitation:
  • Large facial dysmorphoses (ODF treatment or surgery)
  • Loss of posterior wedging uncompensated (restoration in odontology)
  • Exclusion for tracking difficulties:
  • Lack of motivation of the patient
  • Mutation or planned move

Exclusion

    Key Trial Info

    Start Date :

    November 15 2019

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    February 1 2025

    Estimated Enrollment :

    150 Patients enrolled

    Trial Details

    Trial ID

    NCT03871608

    Start Date

    November 15 2019

    End Date

    February 1 2025

    Last Update

    March 28 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hôpital Gui de Chauliac

    Montpellier, France, 34295